Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis.[1] A related compound, clindamycin, is derived from lincomycin by using thionyl chloride to replace the 7-hydroxy group with a chlorine atom with inversion of chirality.[2]

Starting at
|
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
|
| AHFS/Drugs.com | monograph |
| MedlinePlus | a609005 |
| Pregnancy category |
US : C (Risk not ruled out) |
| Legal status | US: ℞-only |
| Routes of administration |
IM/IV |
| Bioavailability | N/A |
|---|---|
| Biological half-life | 5.4 ± 1.0 hours after IM or IV administration |
| Excretion | renal and biliary |
| CAS Number | 154-21-2 |
| ATC code | J01FF02 |
| PubChem | CID: 3000540 |
| DrugBank | DB01627 |
| ChemSpider | 2272112 |
| UNII | BOD072YW0F |
| KEGG | D00223 |
| ChEBI | CHEBI:6472 |
| ChEMBL | CHEMBL1447 |